We create custom-designed and cost-effective medical testing products that meet the needs of even the most complex diagnostic challenges
Custom tools for better healthcare
GobiX GmbH is a Swiss MedTech start-up that is innovating the field of diagnostics using the most advanced and adaptable 3D printing technologies.
Want to hear more? We guide your project from first idea to roll-out:
Swabs for COVID-19 testing
Our solution: A scalable, fast system with custom swabs and transportation fluid protection that can be printed on demand.
Custom tick mortar
Saliva collection tool
Our solution: An intricate microtube system that reduces air and guarantees a fixed amount of saliva in each tube.
Michel Bielecki, MD
MedTech and AI applications specialist with extensive entrepreneurial experience. Currently involved in multiple research projects in the public health sector with the University of Zurich and the Swiss Armed Forces. MMed, University of Zurich.
3D printing specialist with extensive work experience in automotive production management. Former product developer for an exoskeleton prototype currently used for academic teaching within an ETH Zürich medicine lecture. MSc in Mechanical Engineering (Swiss Federal Institute of Technology, ETH Zurich)
Jennifer de Broglie
Sales and product specialist, MBA (University of Dallas)
Marketing and business development specialist. BA in International Studies and Management (Boston College), in progress MSc Management & Technology (Technical University of Munich).
Physician actively involved in COVID-19 related research and clinical work with the Swiss Armed Forces and NATO. MMed (University of Zurich) and Doctoral Candidate (University of Bern).
“Having access to tests and to test kits is so important especially in resource limited, vulnerable countries, which is what GobiX is helping with. The WHO mantra on the control of COVID-19 is simple and effective and reads “TEST, TEST; TEST” Without tests, developing countries will not be able to monitor and control the spread of COVID-19.”Prof. Dr. Patricia SchlagenhaufAdvisor to GobiX, Co-Director of the WHO Collaborating Centre for Travellers’ Health
Today, the key to fighting COVID-19 is simply identifying those who are infected as early as possible. This is the motivation behind our collaboration with GobiX and Formlabs - we are teaming to address the critical need for tools and equipment needed to safely collect and transport viral samples. We are extremely proud that our solution will contribute to accurate testing during this global crisis.Adrian HärriCEO, Biolytix AG